BRPI0703731A - dispositivo bioabsorvìvel tendo aditivos encapsulados para aceleração da degradação - Google Patents

dispositivo bioabsorvìvel tendo aditivos encapsulados para aceleração da degradação

Info

Publication number
BRPI0703731A
BRPI0703731A BRPI0703731-7A BRPI0703731A BRPI0703731A BR PI0703731 A BRPI0703731 A BR PI0703731A BR PI0703731 A BRPI0703731 A BR PI0703731A BR PI0703731 A BRPI0703731 A BR PI0703731A
Authority
BR
Brazil
Prior art keywords
degradation
biodegradable
microparticle
nanoparticle
bioabsorbable
Prior art date
Application number
BRPI0703731-7A
Other languages
English (en)
Inventor
George Landau
Vipul Dave
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0703731A publication Critical patent/BRPI0703731A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/129—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K2103/00—Materials to be soldered, welded or cut
    • B23K2103/30—Organic materials
    • B23K2103/42—Plastics other than composite materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K2103/00—Materials to be soldered, welded or cut
    • B23K2103/50—Inorganic materials other than metals or composite materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DISPOSITIVO BIOABSORVìVEL TENDO ADITIVOS ENCAPSULADOS PARA ACELERAçãO DA DEGRADAçãO. Refere-se a um dispositivo médico que tem uma estrutura produzida de um material biodegrável e/ou bioabsorvível. Um aditivo de degradação é encapsulado por outro material biodegrável e/ou bioabsorvível formando uma nanopartícula ou micropartícula. A nanopartícula ou micropartícula está junto com o material biodegrável e/ou bioabsorvível da estrutura, O outro material biodegrável e/ou bioabsorvível da nanopartícula ou micropartícula tem uma taxa de degradação que é mais rápida do que uma taxa de degradação do um material biodegrável e/ou bioabsorvível. A estrutura experimenta um período de degradação acelerada após liberação do aditivo de degradação a partir da nanopartícula ou micropartícula.
BRPI0703731-7A 2006-10-06 2007-10-08 dispositivo bioabsorvìvel tendo aditivos encapsulados para aceleração da degradação BRPI0703731A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/539,393 US8828419B2 (en) 2006-10-06 2006-10-06 Bioabsorbable device having encapsulated additives for accelerating degradation

Publications (1)

Publication Number Publication Date
BRPI0703731A true BRPI0703731A (pt) 2008-05-27

Family

ID=38988231

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0703731-7A BRPI0703731A (pt) 2006-10-06 2007-10-08 dispositivo bioabsorvìvel tendo aditivos encapsulados para aceleração da degradação

Country Status (10)

Country Link
US (1) US8828419B2 (pt)
EP (1) EP1911472B1 (pt)
JP (1) JP5133023B2 (pt)
KR (1) KR101392785B1 (pt)
CN (1) CN101195046B (pt)
AU (1) AU2007216921B2 (pt)
BR (1) BRPI0703731A (pt)
CA (1) CA2605791C (pt)
IL (1) IL186190A (pt)
MX (1) MX2007012485A (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040260398A1 (en) * 2003-02-10 2004-12-23 Kelman David C. Resorbable devices
GB0329654D0 (en) * 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
CA2619571A1 (en) * 2005-08-18 2007-02-22 Smith & Nephew, Plc High strength devices and composites
WO2007103276A2 (en) 2006-03-03 2007-09-13 Smith & Nephew, Inc. Systems and methods for delivering a medicament
CA2679365C (en) * 2006-11-30 2016-05-03 Smith & Nephew, Inc. Fiber reinforced composite material
EP2142353A1 (en) 2007-04-18 2010-01-13 Smith & Nephew PLC Expansion moulding of shape memory polymers
ATE547129T1 (de) 2007-04-19 2012-03-15 Smith & Nephew Inc Multimodale formgedächtnis-polymere
JP5680957B2 (ja) 2007-04-19 2015-03-04 スミス アンド ネフュー インコーポレーテッドＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ，Ｉｎｃ． グラフト固定
US8998978B2 (en) * 2007-09-28 2015-04-07 Abbott Cardiovascular Systems Inc. Stent formed from bioerodible metal-bioceramic composite
EP2244698A1 (en) * 2008-02-25 2010-11-03 The University Of North Carolina At Charlotte Office Of Technology Transfer Biodegradable therapeutic nanoparticles containing an antimicrobial agent
US20090228097A1 (en) * 2008-03-07 2009-09-10 Abbott Cardiovascular Systems Inc. A1 Adenosine Receptor Antagonist-Coated Implantable Medical Device
DE102008044316A1 (de) * 2008-12-03 2010-06-10 Biotronik Vi Patent Ag Wirkstoffbeschichtetes Medizinprodukt, Verfahren zu dessen Herstellung und dessen Verwendungen
US20110066141A1 (en) * 2009-09-11 2011-03-17 Cook Incorporated Implantable medical device having an anti-gastric distress agent
US20220175370A1 (en) * 2010-09-30 2022-06-09 Cilag Gmbh International Tissue thickness compensator comprising at least one medicament
CN102599995B (zh) * 2011-01-19 2016-08-03 广西南宁博恩康生物科技有限公司 双层结构的管道支架及其制备方法
US8487017B2 (en) * 2011-06-27 2013-07-16 Covidien Lp Biodegradable materials for orthopedic devices based on polymer stereocomplexes
KR101273034B1 (ko) * 2011-11-14 2013-06-10 (주)이화바이오메딕스 생분해성 약물전달 필름을 구비하는 생분해성 스텐트
FR2984354A1 (fr) 2011-12-20 2013-06-21 Centre Nat Rech Scient Procede de preparation d'alliage polymere/enzymes
US20150328373A1 (en) * 2014-05-19 2015-11-19 Abbott Cardiovascular Systems Inc. Additives To Increase Degradation Rate Of A Biodegradable Scaffolding And Methods Of Forming Same
CN104001221B (zh) * 2014-06-10 2016-03-09 上海锦葵医疗器械有限公司 一种降解速率可控的显影生物心脏封堵器
US11331191B2 (en) 2015-08-12 2022-05-17 Howmedica Osteonics Corp. Bioactive soft tissue implant and methods of manufacture and use thereof
US10729548B2 (en) 2016-05-02 2020-08-04 Howmedica Osteonics Corp. Bioactive soft tissue implant and methods of manufacture and use thereof
CA2938576A1 (en) 2015-08-12 2017-02-12 Howmedica Osteonics Corp. Methods for forming scaffolds
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
AU2018305161A1 (en) * 2017-07-25 2020-01-30 PK Med SAS Drug delivery composition
WO2019222482A1 (en) * 2018-05-16 2019-11-21 Spirox, Inc. Allergic rhinitis drug delivery implant
MA53291A (fr) * 2018-08-10 2022-05-11 Ephemeral Solutions Inc Particules contenant des agents colorants et procédés pour les utiliser
CN109293008A (zh) * 2018-11-07 2019-02-01 太原理工大学 一种复合生物酶及其应用于处理造纸工业废水的方法
US11794161B1 (en) 2018-11-21 2023-10-24 Trucapsol, Llc Reduced permeability microcapsules
US11571674B1 (en) 2019-03-28 2023-02-07 Trucapsol Llc Environmentally biodegradable microcapsules
US11542392B1 (en) * 2019-04-18 2023-01-03 Trucapsol Llc Multifunctional particle additive for enhancement of toughness and degradation in biodegradable polymers
CN112441742A (zh) * 2019-08-30 2021-03-05 江苏启灏医疗科技有限公司 生物活性玻璃、鼻腔支架复合材料及其应用
CN114901753B (zh) * 2020-01-05 2024-10-11 加利福尼亚大学董事会 具有可编程降解和微塑料消除的生物活性塑料
US11484857B2 (en) 2020-01-30 2022-11-01 Trucapsol Llc Environmentally biodegradable microcapsules
CN111110929B (zh) * 2020-02-15 2020-12-22 深圳脉动医学技术有限公司 一种高生物安全性心脏支架及其制造方法
AU2021318848A1 (en) * 2020-07-31 2023-03-23 Kimberly-Clark Worldwide, Inc. Auto-biodegradable absorbent articles
US12383246B2 (en) 2020-10-12 2025-08-12 Abbott Cardiovascular Systems, Inc. Vessel closure device with improved safety and tract hemostasis
US20220226627A1 (en) * 2021-01-15 2022-07-21 Covidien Lp Surgical stapling device with therapeutic suppository
TWI807721B (zh) * 2021-04-07 2023-07-01 仆派海洋生技股份有限公司 珊瑚養殖方法、系統及其製品
US12302933B2 (en) 2021-06-25 2025-05-20 Trucapsol Llc Flavor delivery system
US12187829B2 (en) 2021-08-12 2025-01-07 Trucapsol Llc Environmentally biodegradable microcapsules
CN114176698B (zh) * 2021-12-20 2024-04-26 神遁医疗科技(上海)有限公司 一种栓塞物
CN114378434A (zh) * 2022-03-04 2022-04-22 湖北中航精机科技有限公司 用于高调器封口焊接的激光焊接系统及方法
US11878280B2 (en) 2022-04-19 2024-01-23 Trucapsol Llc Microcapsules comprising natural materials
US11904288B1 (en) 2023-02-13 2024-02-20 Trucapsol Llc Environmentally biodegradable microcapsules
US11969491B1 (en) 2023-02-22 2024-04-30 Trucapsol Llc pH triggered release particle
KR102644219B1 (ko) * 2023-07-21 2024-03-07 주식회사 에너지마이닝 신절단신경 재생 극대화를 위한 마찰전기 발전소자가 결합된 생분해성 하이드로겔 신경도관

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US5290271A (en) * 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
WO1991017789A1 (en) 1990-05-18 1991-11-28 Stack Richard S Bioabsorbable stent
US5629077A (en) * 1994-06-27 1997-05-13 Advanced Cardiovascular Systems, Inc. Biodegradable mesh and film stent
AU3795395A (en) * 1994-11-30 1996-06-06 Ethicon Inc. Hard tissue bone cements and substitutes
US6065476A (en) 1994-12-21 2000-05-23 Board Of Regents, University Of Texas System Method of enhancing surface porosity of biodegradable implants
US6419945B1 (en) * 1996-01-17 2002-07-16 Cambridge Scientific, Inc. Buffered resorbable internal fixation devices and methods for making material therefore
US5817328A (en) * 1996-01-17 1998-10-06 Cambridge Scientific, Inc. Material for buffered resorbable internal fixation devices and method for making same
US6241771B1 (en) * 1997-08-13 2001-06-05 Cambridge Scientific, Inc. Resorbable interbody spinal fusion devices
US7033603B2 (en) * 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
US6338739B1 (en) * 1999-12-22 2002-01-15 Ethicon, Inc. Biodegradable stent
US6913765B2 (en) * 2001-03-21 2005-07-05 Scimed Life Systems, Inc. Controlling resorption of bioresorbable medical implant material
GB0116341D0 (en) * 2001-07-04 2001-08-29 Smith & Nephew Biodegradable polymer systems
WO2003026532A2 (en) 2001-09-28 2003-04-03 Boston Scientific Limited Medical devices comprising nanomaterials and therapeutic methods utilizing the same
ATE295155T1 (de) 2001-10-05 2005-05-15 Surmodics Inc Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
US8740973B2 (en) * 2001-10-26 2014-06-03 Icon Medical Corp. Polymer biodegradable medical device
US7790141B2 (en) * 2003-08-11 2010-09-07 Pathak Holdings, Llc Radio-opaque compounds, compositions containing same and methods of their synthesis and use
US7785615B2 (en) * 2004-05-28 2010-08-31 Cordis Corporation Biodegradable medical implant with encapsulated buffering agent
US7803182B2 (en) 2004-05-28 2010-09-28 Cordis Corporation Biodegradable vascular device with buffering agent
KR20070100836A (ko) 2005-02-03 2007-10-11 신벤션 아게 졸/겔 기술에 의하여 제조된 약물 전달 물질
US9248034B2 (en) * 2005-08-23 2016-02-02 Advanced Cardiovascular Systems, Inc. Controlled disintegrating implantable medical devices

Also Published As

Publication number Publication date
CN101195046A (zh) 2008-06-11
CA2605791A1 (en) 2008-04-06
HK1115550A1 (en) 2008-12-05
IL186190A0 (en) 2008-11-03
JP2008110205A (ja) 2008-05-15
AU2007216921B2 (en) 2013-06-27
EP1911472A1 (en) 2008-04-16
CN101195046B (zh) 2014-03-05
KR101392785B1 (ko) 2014-05-09
US8828419B2 (en) 2014-09-09
CA2605791C (en) 2014-03-11
US20080085297A1 (en) 2008-04-10
KR20080031842A (ko) 2008-04-11
AU2007216921A1 (en) 2008-04-24
EP1911472B1 (en) 2015-02-25
IL186190A (en) 2014-07-31
JP5133023B2 (ja) 2013-01-30
MX2007012485A (es) 2009-02-16

Similar Documents

Publication Publication Date Title
BRPI0703731A (pt) dispositivo bioabsorvìvel tendo aditivos encapsulados para aceleração da degradação
EP1908484A3 (en) Bioabsorbable device having composite structure for accelerating degradation
BR112014005354A2 (pt) gerenciamento de padrão de ativação
IN2012DN00570A (pt)
ECSP109873A (es) Mezclas secas de material para construcción modificadas con polímero
BR112012029293A2 (pt) matriz sintética absorvível reforçada para aplicações hemostáticas
BR112013031389A2 (pt) instrumento cirúrgico
EP1992676A4 (en) ORGANOMOLYBDEN ADDITIVE, PREPARATION THEREOF, AND LUBRICANT COMPOSITION CONTAINING THE ADDITIVE, AND USES THEREOF
BR112013028497A2 (pt) estabelecendo permissões para ligações encaminhadas em mensagens eletrônicas
BRPI0709359A8 (pt) Composição de tinta para jato de tinta, método para formar uma tinta para jato de tinta e sistema de tinta para jato de tinta
WO2007150075A3 (en) Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
BR112015009446A2 (pt) dispositivos ajustáveis para tratar artrite de joelho
BR212012031500U2 (pt) composições sólidas
BR112016007120A2 (pt) partícula de liberação contendo agente de benefício à base de copolímero de estireno e anidrido maleico
BR112017004493A2 (pt) composições de polímeros
BR112015022772A8 (pt) método para formar um dispositivo implantável, e o referido dispositivo
UY31698A (es) Preparacion solida de desintegracion oral
NZ602000A (en) Methods and compositions to treat hemorrhagic conditions of the brain
BR112013031801B8 (pt) artigo de fumar compreendendo material de tabaco contendo micropartículas não isométricas de carbonato de cálcio e seu método
BR112013012737A2 (pt) "composição aditiva e composição polimérica compreendendo a mesma."
BR112012026818A2 (pt) sistema de fixação de osso incluindo a compressão do fio k
BR112015030499A2 (pt) sistema de bandeja para porta com trilho
BRPI0821616B8 (pt) composição micelar de copolímero de bloco anfifílico contendo taxano e método para preparação da mesma
BR112014029631A2 (pt) âncora híbrida
EP2395048A3 (en) Polymers compositions including an antioxidant

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2154 DE 17/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL